TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
SRPT

Sarepta Therapeutics Inc

Healthcare · Biotechnology

18.70$ +1.5% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Sarepta Therapeutics Inc (SRPT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,189 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet SRPT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
3,110 3,265 3,224 3,424 3,600 3,963 3,465 3,680 3,493 3,350 3,179 3,189
2,451 2,579 2,465 2,684 2,685 3,073 2,433 2,657 2,722 2,538 2,310 2,224
542 428 427 384 198 1,103 241 511 613 801 464 571
1,734 1,676 1,391 1,460 1,198 1,355 523 800 851 940 653 788
354 437 419 392 516 650 725 610 542 520 548 483
244 323 374 486 566 750 941 994 1,077 915 1,001 904
20 30 29 28 28 27 26 31 30 29 31 31
2,345 2,405 2,263 2,347 2,379 2,435 2,323 2,322 2,173 2,209 1,674 1,661
451 654 609 688 699 732 606 920 921 1,095 499 503
322 123 106 92 92 13 – – 10 11 – –
88 165 92 107 119 214 156 137 94 281 70 51
1,237 1,133 1,134 1,135 1,136 1,137 1,138 1,139 1,035 829 838 848
764 859 961 1,077 1,221 1,528 1,143 1,357 1,320 1,141 1,505 1,528
-4,492 -4,446 -4,410 -4,404 -4,370 -4,211 -4,658 -4,462 -4,642 -4,877 -4,546 -4,551
89 106 99 99 100 108 97 107 100 105 122 105

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?